The Gemini Report – Investment Deep Dives

Comprehensive Investment Research: Givaudan SA (GIVN.SW)

All investment deep dives on this site have been written by Google Gemini with light human editing. Nothing on this site constitutes investment advise. All materials on this site are for informational purposes only.

The Gemini Report - Investment Deep Dives
The Gemini Report – Investment Deep Dives
Comprehensive Investment Research: Givaudan SA (GIVN.SW)
Loading
/

I. Executive Summary & Investment Thesis

This report provides a comprehensive investment analysis of Givaudan SA (GIVN.SW), the global leader in the flavor and fragrance (F&F) industry. The analysis is structured to provide a foundational due diligence framework, assessing the company’s strategic positioning, financial performance, valuation, and key risks, without providing a specific investment recommendation or price target.

The central investment thesis for Givaudan is characterized by a fundamental tension: it is an exceptionally high-quality, wide-moat business operating in a structurally attractive oligopoly, yet it consistently trades at a premium valuation that reflects these strengths. The decision for a prospective investor hinges on whether the company’s superior and resilient performance justifies this premium, particularly in the face of persistent macroeconomic and regulatory headwinds.

A. Key Investment Merits

Givaudan’s investment merits are rooted in its durable competitive advantages and consistent financial execution. The company is the undisputed market leader in the consolidated F&F industry, which benefits from high barriers to entry, including immense scale, proprietary intellectual property, and deep regulatory expertise. Its business model is exceptionally resilient, with revenues tied to non-discretionary consumer staples and characterized by high “stickiness.” This is due to a co-creation process where Givaudan’s products become integral to a customer’s final product formula, creating significant switching costs despite representing a small fraction of the end-product cost.

Financially, the company has demonstrated consistent above-market organic growth, significant pricing power to offset inflation, and robust free cash flow generation, which comfortably exceeds 12% of sales. This financial strength supports a disciplined capital allocation strategy focused on value-accretive bolt-on acquisitions and a progressive dividend, which has been increased for 24 consecutive years.

B. Key Investment Concerns

The primary concern for investors is Givaudan’s perennially premium valuation. Its price-to-earnings (P/E) and enterprise value-to-EBITDA (EV/EBITDA) multiples trade at a significant premium to the broader market and many industry peers, offering little margin of safety against execution missteps or external shocks. The company faces material financial risks from adverse currency movements, particularly the strength of its reporting currency, the Swiss Franc (CHF), which consistently dampens reported growth.

Operationally, the business is exposed to the volatility of raw material prices, which can pressure margins if not fully passed through to customers. Furthermore, the company faces a shifting and increasingly stringent regulatory environment, especially in Europe, which could necessitate costly product reformulations. A significant, and perhaps underappreciated, risk is the ongoing industry-wide antitrust investigation by European and Swiss authorities, which could result in substantial financial penalties and reputational damage.

C. Critical Factors & Catalysts

Future performance will be driven by a distinct set of factors. Critically, investors should monitor Givaudan’s ability to maintain its recent strong volume growth while preserving the pricing discipline that has protected its margins. The success of its strategic forays into higher-growth adjacencies, such as Active Beauty and Health & Wellbeing solutions, will be a key determinant of future growth. Continued market share gains with faster-growing local and regional customers represent a significant opportunity.

Potential catalysts that could influence the stock’s performance include a favorable resolution or clarification of the ongoing antitrust probe, which would remove a major overhang of uncertainty. A sustained period of raw material cost deflation could provide a significant tailwind to gross margins, potentially leading to earnings outperformance. Conversely, any failure to meet its high growth and profitability expectations could lead to a significant de-rating of its premium valuation multiples.

II. Company Overview & Business Model

Givaudan SA is a Swiss-domiciled multinational and the global leader in the creation and manufacturing of flavors, fragrances, and active cosmetic ingredients.1 Founded in 1895, the company has a rich heritage of innovation and strategic expansion, establishing itself as an essential partner to the global consumer goods industry.1 Its products are found in a vast array of consumer end-markets, from beverages and savory foods to fine perfumes and laundry detergents.1 The business is organized into two core divisions, Taste & Wellbeing and Fragrance & Beauty, which are roughly equal in size and create a naturally hedged and diversified portfolio.2

A. Business Segments Deep Dive

Givaudan’s dual-segment structure allows it to capture a broad spectrum of consumer trends and demand drivers, balancing the dynamics of food and beverage markets with those of personal and household care.

  • Taste & Wellbeing: This division is a leading provider of flavor and taste solutions for the global food and beverage industry. Its offerings are categorized into key end-markets: Beverages (36% of segment sales), Savoury (37%), Dairy (12%), and Sweet Goods (15%).5 For the full fiscal year 2024, the Taste & Wellbeing division generated sales of CHF 3,752 million.6 Beyond traditional flavors, the division has strategically expanded into functional and nutritional ingredients, developing solutions that cater to the powerful consumer trend towards health and wellness. This includes technologies for sugar and salt reduction, plant-based protein taste masking, and other ingredients that enhance the nutritional profile of food products.7
  • Fragrance & Beauty: This division creates fragrances and beauty solutions for a wide range of products. It operates across three main business units: Fine Fragrances (21% of segment sales), Consumer Products (63%), and Fragrance Ingredients & Active Beauty (16%).5 For the full fiscal year 2024, the Fragrance & Beauty division reported sales of CHF 3,660 million.6 The Consumer Products unit serves the large personal care, home care, and fabric care markets, while the Fine Fragrances unit collaborates with the world’s most prestigious perfume brands. The division has also made a strategic push into Active Beauty, providing scientifically-backed active cosmetic ingredients for skincare and haircare, a segment with high growth and margin potential.2 Notably, the Fine Fragrance business has demonstrated exceptional, double-digit growth in the post-pandemic period, driven by a “lipstick effect” and premiumization trends.10

B. Revenue Composition Analysis

A core strength of Givaudan’s business model is its extensive diversification across geographies, market maturities, and customer types, which provides significant resilience and hedges against localized downturns or shifts in demand.

  • By Geography (FY2024): The company has a well-balanced global footprint. Europe, Africa, and the Middle East (EAME) is the largest region, accounting for 40% of sales. It is followed by Asia Pacific at 25%, North America at 23%, and Latin America at 12%.6 This geographic spread ensures that the company is not overly reliant on any single economic region.
  • By Market Maturity (FY2024): Revenue is almost evenly split between mature markets (53% of sales) and high-growth markets (47% of sales).6 This structure provides a stable, cash-generative base from developed economies combined with significant growth exposure to the rising middle-class consumer in emerging economies.
  • By Customer Type (FY2024): Givaudan serves both large multinational corporations and smaller, more nimble players. Sales to global customers account for 42% of the total, while a majority, 58%, comes from local and regional customers.6 This customer mix is a crucial and often underappreciated strength. While global consumer packaged goods (CPG) giants provide scale and stability, local and regional brands are often the primary drivers of growth and innovation, particularly in emerging markets where they are better attuned to local tastes. Management explicitly highlighted the “exceptional performance with the local and regional customers” in its 2024 results, underscoring this segment’s importance as a growth engine.12 This diversification reduces customer concentration risk and allows Givaudan to participate in the most dynamic part of the consumer goods market.

C. Market Position & Scale

Givaudan is the world’s largest company in the flavor and fragrance industry, a leadership position it has solidified through decades of organic growth and strategic acquisitions.1 The company’s global scale is a formidable competitive advantage, encompassing over 16,942 employees, 162 locations worldwide, including 78 production sites and 62 creation and research centers.3 This extensive network enables Givaudan to serve its diverse customer base with localized solutions while leveraging global efficiencies in R&D, procurement, and manufacturing.

D. Revenue Stickiness & Customer Integration

The nature of Givaudan’s customer relationships results in highly stable and recurring revenue streams. Its products, while critical to the sensory identity and consumer appeal of a customer’s brand, typically represent a very small percentage of the end-product’s total cost—often in the range of 0.5% to 2%.15 This low cost makes customers less sensitive to price increases for what is a highly differentiating ingredient.

Crucially, Givaudan’s flavors and fragrances are not off-the-shelf commodities. They are custom-made solutions developed through a deep, collaborative co-creation process with clients.1 Givaudan’s teams often work as an extension of their customers’ R&D departments to develop the perfect scent or taste profile for a new product. Once a Givaudan formulation is designed into a successful product like a blockbuster perfume or a leading beverage brand, it becomes integral to that product’s identity. The intellectual property for these custom formulas is owned by Givaudan, not the customer.15 This creates extremely high switching costs, as changing the flavor or fragrance would mean fundamentally altering the end product and risking consumer acceptance. This dynamic locks in customers for the life cycle of their products, leading to annuity-like revenue streams and exceptional business model resilience.

III. Industry Dynamics & Market Structure

The global Flavors & Fragrances (F&F) industry is a structurally attractive market characterized by steady, defensive growth, high barriers to entry, and a rational competitive landscape. Its performance is intrinsically linked to the resilient demand for essential consumer goods, making it less susceptible to economic cycles than many other sectors.

A. Market Size & Growth Trajectory

The F&F market is a large, multi-billion-dollar industry. Market size estimates for 2024 vary slightly depending on the scope of the analysis, but generally fall within the range of USD 30.6 billion to USD 35.3 billion.16 The industry is projected to grow at a compound annual growth rate (CAGR) of between 3.7% and 5.5% over the next five to six years.16 This growth is underpinned by stable, long-term drivers such as global population growth, rising disposable incomes in emerging markets, and continuous innovation in end-use categories like food, beverages, personal care, and household products. The defensive nature of these end-markets provides a consistent baseline of demand.

B. Competitive Moats & Barriers to Entry

The F&F industry is protected by a confluence of formidable and enduring barriers to entry, which insulate incumbent leaders from new competition.

  • Scale and R&D Investment: The sheer scale of the leading players is a primary barrier. Givaudan, for example, invests 7-8% of its multi-billion-dollar sales into research and development annually, an absolute level of spending that no new entrant could hope to match.13 This funds the maintenance of vast ingredient libraries, the discovery of novel molecules, and a global network of creation centers.
  • Customer Integration and Switching Costs: As detailed previously, the co-creation business model embeds F&F suppliers deeply within their customers’ product development processes. The resulting custom formulas, owned by the F&F company, create exceptionally high switching costs, making customer relationships long-term and sticky.15
  • Regulatory Expertise: The industry is governed by a complex and constantly evolving global web of food safety, chemical, and environmental regulations. Navigating these requirements in over 100 countries demands significant dedicated resources and expertise, representing a major hurdle for smaller firms.20
  • Intellectual Property: The core of the industry’s value lies in its intellectual property. The proprietary formulas for thousands of flavors and fragrances, protected as trade secrets and supported by a vast portfolio of patents (Givaudan holds over 5,000 active patents), are nearly impossible for competitors to replicate.8

C. Market Consolidation & Share Dynamics

The F&F market is a classic oligopoly, characterized by a high degree of concentration. The industry is dominated by four major players: Givaudan, DSM-Firmenich, International Flavors & Fragrances (IFF), and Symrise AG.6 Together, these top companies are estimated to control between 75% and 80% of the global market.24 This consolidated structure leads to a generally rational competitive environment, where the main players tend to compete on innovation, service, and quality rather than engaging in destructive price wars. The most significant recent structural change was the merger of equals between DSM and Firmenich, which was completed in May 2023.25 This created a new, formidable competitor with a combined scale and portfolio that intensifies competition at the highest level of the industry.

D. Evolving Consumer & End-Market Trends

The F&F industry is directly influenced by major shifts in consumer preferences, which in turn dictate the innovation priorities for both F&F companies and their CPG customers.

  • Natural & Clean Label: The most powerful and pervasive trend is the consumer-driven demand for natural, organic, and “clean label” products, free from artificial ingredients.16 This trend is forcing widespread product reformulation across the food, beverage, and personal care industries, creating significant demand for natural flavors and fragrances derived from botanical and other natural sources.
  • Health & Wellness: Consumers are increasingly seeking products that offer functional benefits beyond basic needs. In the F&F space, this translates into growing demand for ingredients that support health and wellbeing. Examples include natural taste-masking solutions for plant-based proteins, flavor systems that allow for significant sugar and salt reduction without compromising taste, and fragrances designed to have mood-enhancing or wellness-promoting properties.19
  • Sustainability & Traceability: A growing awareness of environmental and social issues is leading consumers and, by extension, CPG companies to demand greater transparency and sustainability in supply chains. This places a premium on F&F companies that can provide ingredients that are not only natural but also responsibly and traceably sourced.29

The powerful trend towards natural and clean-label ingredients, while representing a significant growth opportunity, also introduces substantial operational challenges. This dynamic, however, paradoxically strengthens the competitive position of the largest, most sophisticated players like Givaudan. Natural raw materials are inherently more volatile than their synthetic counterparts in terms of price, quality, and supply, being subject to agricultural variables like weather, crop cycles, and geopolitical stability in diverse sourcing regions. Managing a global supply chain that procures thousands of distinct natural ingredients from over 100 countries requires an immense, resilient, and ethically governed infrastructure.30 Givaudan’s investment in its “Sourcing4Good” program is a direct strategic response to this complexity.7 Smaller competitors simply lack the scale, purchasing power, risk management capabilities, and global footprint necessary to build and maintain such a complex sourcing network. Consequently, the very trend that fuels market demand also elevates the barriers to entry, turning a potential supply chain risk into a key competitive differentiator for the industry leaders.

IV. Competitive Position & Market Leadership

Givaudan’s status as the industry leader is not merely a function of its size but is underpinned by a set of durable competitive advantages that have allowed it to consistently outperform its peers and the broader market. The company’s strategy is focused on leveraging these advantages to drive innovation and deepen customer relationships.

A. Peer Benchmark Analysis

Givaudan’s primary competitors are the other members of the “Big Four” in the F&F industry: International Flavors & Fragrances (IFF), Symrise AG, and the newly formed DSM-Firmenich.6 While direct, audited market share data is proprietary and not publicly disclosed, Givaudan’s long-standing position as the largest company by revenue is well-established in the industry.1

More importantly, a comparative analysis of financial metrics reveals Givaudan’s superior operational performance. Historically, the company has maintained higher and more stable profitability, as evidenced by its leading EBITDA margins and robust free cash flow conversion. This consistent, high-quality financial performance is a key factor that supports the premium valuation at which its stock typically trades relative to its peers.

The recent merger of DSM and Firmenich has created a powerful new entity, dsm-firmenich, with significant scale and a broad portfolio, particularly strong in nutrition, health, and beauty.31 While this intensifies the competitive landscape, Givaudan’s focused strategy and deeply integrated customer model position it well to defend its leadership.

B. Sources of Competitive Advantage

Givaudan’s market leadership is built on three pillars of competitive advantage that are difficult for rivals to replicate.

  • Innovation & R&D Prowess: Givaudan’s commitment to innovation is its most significant differentiator. The company consistently reinvests a substantial portion of its revenue into R&D—typically between 7% and 8% of sales annually.7 In fiscal year 2024, this investment amounted to 7.6% of sales, or CHF 565 million.8 This level of spending, which is the largest in the industry in absolute terms 13, fuels a powerful innovation engine. It supports a pipeline of novel molecules, advanced biotechnologies for creating sustainable ingredients, and proprietary delivery systems. This continuous expansion of its “palette” of ingredients and technologies allows Givaudan to stay ahead of consumer trends and offer its customers unique, value-added solutions.
  • Supply Chain & Sourcing Mastery: The company’s ability to manage an extraordinarily complex global supply chain is a core operational strength. Givaudan sources over 11,000 different raw materials from more than 3,000 suppliers across more than 100 countries.15 Mastering this complexity involves ensuring quality, managing price volatility, and navigating geopolitical risks. The company has increasingly pursued vertical integration for key natural ingredients, notably through its acquisition of Naturex, to secure supply and enhance traceability.34 This sourcing expertise is critical in an era of rising demand for natural and sustainably sourced ingredients.
  • Customer Relationships & Co-Creation Model: Givaudan’s business model is fundamentally based on partnership, not just sales. Its teams of highly skilled perfumers and flavorists are deeply integrated with customer innovation teams, working collaboratively to co-create solutions for new products.15 This process can take months or even years, resulting in a bespoke solution that is exclusive to the customer. This deep integration makes Givaudan an indispensable innovation partner, fostering long-term relationships that transcend a simple supplier-buyer dynamic.

C. Geographic Presence & Emerging Market Penetration

Givaudan is strategically positioned to capitalize on global growth trends. With 47% of its 2024 sales derived from high-growth markets in Asia-Pacific, Latin America, the Middle East, and Africa, the company has significant exposure to the world’s fastest-growing consumer populations.6 To effectively serve these markets, Givaudan has established a strong local presence, including creation centers, research labs, and production facilities in key regional hubs.14 This allows the company to develop products that are tailored to specific local tastes and cultural preferences, a key factor for success in these diverse regions.

D. Customer Concentration

The company’s customer base is well-diversified, mitigating the risk of over-reliance on a small number of clients. The balanced split of sales between large, global multinational corporations (42%) and smaller, often faster-growing local and regional customers (58%) provides a healthy mix of stability and dynamic growth potential.6 This structure has proven to be a resilient engine for growth, particularly as local brands continue to gain share in many emerging markets.

Table 1: Peer Valuation & Profitability Comparison (Trailing Twelve Months – TTM)

MetricGivaudan SA (GIVN.SW)International Flavors & Fragrances Inc. (IFF)Symrise AG (SY1.DE)dsm-firmenich AG (DSFIR.AS)
Revenue (USD)~$9.5B 3~$11.5B 36~$5.4B (€4.999B) 37~$13.8B (€12.8B) 38
LFL/Organic Growth (FY2024)12.3% 396.0% (Comparable Currency Neutral) 368.7% 374.0% (Pro forma) 38
EBITDA Margin (TTM)~22.4% – 23.8% 6~19.2% (Adjusted Operating) 36~20.7% 37~16.6% (Adjusted) 38
FCF Margin (TTM)~15.6% 40~5.3% 36~18.0% (Operating Cash Flow) 41~12.1% (Adj. Gross Op. FCF) 38
ROIC (TTM)9.62% 40Data Not AvailableData Not AvailableData Not Available
P/E Ratio (TTM)~30.0x 40Not Meaningful due to losses~30.0x – 33.0x (varies)~103.7x (GAAP, highly distorted) 42
EV/EBITDA (TTM)~21.3x 40~12.0x – 13.0x (varies)~20.0x – 22.0x (varies)~13.9x 42
Note: Data is based on the most recent available full-year or trailing-twelve-month figures from provided sources. Peer data may have different reporting standards (e.g., US GAAP vs. IFRS) and definitions for adjusted metrics, requiring careful interpretation. IFF’s reported GAAP earnings have been volatile post-merger, making its P/E ratio less meaningful. dsm-firmenich’s P/E is distorted by merger-related accounting.

V. Financial Performance & Growth History

Givaudan has a distinguished history of delivering consistent growth, industry-leading profitability, and robust cash flow. The company’s performance through the recent period of macroeconomic volatility (2021-2024) has reaffirmed the resilience of its business model and its strong execution capabilities.

A. Revenue Growth Analysis (FY2021-2024)

Givaudan has consistently demonstrated its ability to grow faster than the underlying F&F market. The company’s strategic ambition for the 2021-2025 cycle is to achieve average like-for-like (LFL) sales growth of 4-5% per year.43 Its recent performance has significantly outpaced this target.

  • FY2022: The company posted solid LFL sales growth of 5.3%, reaching total sales of CHF 7.1 billion amidst a challenging operating environment marked by rising input costs and supply chain disruptions.44
  • FY2023: LFL growth moderated to 4.1% on sales of CHF 6.9 billion. This result was characterized by a tale of two drivers: a negative volume/mix development of -2.2% due to widespread customer destocking and consumer “shrinkflation,” which was more than offset by a powerful pricing contribution of +6.3%.10
  • FY2024: Givaudan delivered an exceptionally strong performance, with LFL sales surging by 12.3% to CHF 7.4 billion. This was driven by a significant recovery in volumes, which grew by nearly 10%, complemented by a residual pricing impact of just under 3%, primarily from hyperinflationary markets like Argentina.11

For the four-year period from 2021 to 2024, Givaudan achieved an average LFL sales growth of 7.2%. This performance is well above the high end of its strategic target range, leading management to state that it is “highly likely to exceed” its five-year goal.12

B. Profitability & Margin Evolution

A hallmark of Givaudan’s business quality is its ability to protect and expand profitability. The company demonstrated remarkable pricing power during the inflationary spike of 2022-2023, with management confirming that price increases were implemented to “fully compensate” for the rise in input costs.10

  • EBITDA Margin: The company’s EBITDA margin has shown a positive trajectory. It stood at 20.7% in 2022 44, improved to a reported 21.3% in 2023 (22.4% on a comparable basis) 10, and expanded significantly to a reported 23.8% in 2024 (24.5% on a comparable basis).6
  • This strong margin expansion in 2024 was attributed to three key factors: significant operating leverage from the strong volume rebound, a more “benign raw materials price environment,” and the continued benefits of cost control programs initiated in the prior year.11

C. Working Capital & Cash Flow

Givaudan is a highly cash-generative business, a cornerstone of its investment case. The company’s strategic target is to deliver an average free cash flow (FCF) as a percentage of sales of at least 12% over the five-year cycle.43

  • FY2023: The company achieved a record FCF of CHF 920 million, representing a strong 13.3% of sales.10
  • FY2024: Givaudan surpassed this record, generating an FCF of CHF 1,158 million, equivalent to an impressive 15.6% of sales.12

This robust and consistent cash generation provides the financial firepower to fund all of the company’s capital allocation priorities, including organic investments, bolt-on acquisitions, and a steadily increasing dividend to shareholders.

D. Returns on Capital

Givaudan’s ability to generate attractive returns on the capital it employs is a key measure of its value creation.

  • Return on Invested Capital (ROIC): For the trailing twelve months, Givaudan’s ROIC was 9.62%.40 While this is a solid return, it is essential to compare it against the company’s weighted average cost of capital (WACC) to confirm that it is generating economic profit. Given the low-risk nature of the business and low borrowing costs, it is highly probable that ROIC exceeds WACC.
  • Return on Equity (ROE): For the trailing twelve months, the company’s ROE was a strong 25.99% 40, reflecting efficient use of shareholder equity to generate profits.

Table 2: Givaudan Historical Financial Performance Summary (FY2021-2024)

MetricFY 2021FY 2022FY 2023FY 2024
Revenue (CHF m)6,684 77,117 446,915 107,412 12
LFL Growth (%)7.1% 75.3% 444.1% 1012.3% 12
Reported Growth (%)5.7% 76.5% 44-2.8% 107.2% 12
Gross Profit (CHF m)2,855 72,762 332,846 333,271 40
Gross Margin (%)42.7% 738.8% 3341.2% 3344.1% 40
EBITDA (CHF m)1,482 71,476 441,473 101,765 12
EBITDA Margin (%)22.2% 720.7% 4421.3% 1023.8% 12
Net Income (CHF m)821 7856 44893 101,090 12
Net Margin (%)12.3% 712.0% 4412.9% 3314.7% 12
Free Cash Flow (CHF m)843 7479 44920 101,158 12
FCF as % of Sales12.6% 76.7% 4413.3% 1015.6% 12
EPS – Basic (CHF)89.03 4092.83 3396.81 33118.17 3
Dividend per Share (CHF)66.00 767.00 4468.00 1070.00 (Proposed) 12
Source: Givaudan Annual/Full Year Results Media Releases and Financial Reports.3

VI. Growth Opportunities & Strategic Initiatives

Givaudan’s forward-looking strategy is designed to build upon its core strengths while systematically expanding into adjacent, high-growth areas. The “Committed to Growth, with Purpose” 2025 strategy serves as the roadmap, focusing on portfolio expansion, customer reach, and targeted initiatives in future-facing market segments.7

A. Key Growth Drivers (2025 Strategy)

The company’s strategy is underpinned by three primary growth drivers:

  1. Expand the Portfolio: Givaudan is actively moving beyond its traditional flavor and fragrance core into complementary and higher-growth adjacencies. This includes a significant push into natural food colors, solidified by the acquisition of DDW 34, and a deeper focus on Active Beauty, which involves providing scientifically-proven active ingredients for cosmetics.
  2. Extend Customer Reach: A key strategic priority is to deepen penetration with the fast-growing segment of local and regional customers, which now account for a majority of sales. Simultaneously, the company continues to invest heavily in high-growth emerging markets to capture the demand from a rising global middle class.
  3. Focused Strategies for High-Growth Spaces: Givaudan is dedicating significant resources to specific high-potential areas. These include developing comprehensive solutions for the plant-based food category, expanding its Health & Wellbeing portfolio (e.g., sugar reduction), and pioneering sustainable solutions that meet the growing demand for environmentally friendly products.

B. Expansion in Emerging Markets

High-growth markets are a critical engine for Givaudan’s future, a fact underscored by the impressive 19.5% LFL growth achieved in these regions in 2024.12 The company’s strategy involves more than just exporting products; it is about building a deep local presence. Givaudan has invested in a network of regional innovation hubs, such as those recently opened in Dubai and Singapore, to facilitate co-creation with local customers and develop products that are finely tuned to regional tastes and preferences.35 This on-the-ground presence is a key competitive advantage.

C. Digital Transformation & Technology Investments

Givaudan is proactively integrating digital tools and advanced technologies to enhance its innovation capabilities and operational efficiency. The company is leveraging Artificial Intelligence (AI) to accelerate the creation process. A prime example is the acquisition of Myrissi, a company whose technology can translate fragrances into color patterns and images, providing a novel way to communicate scent concepts to customers.7 Furthermore, Givaudan is developing digital co-creation platforms that allow for more seamless and efficient collaboration with its customers, shortening development timelines and improving outcomes.35

D. Sustainability as a Business Driver

For Givaudan, sustainability is not a peripheral corporate social responsibility initiative but a core component of its business strategy and a source of competitive advantage. The company’s ambitious goals, such as becoming “climate positive” before 2050 and sourcing 100% of materials responsibly by 2030, are deeply integrated into its operations.1 By offering a portfolio of sustainably sourced, traceable, and biodegradable ingredients, Givaudan directly meets a critical and growing demand from its CPG customers, who are themselves facing pressure from end-consumers. This leadership in sustainability allows Givaudan to differentiate its offerings, strengthen partnerships with sustainability-focused customers, and often command a premium for its value-added solutions.

A close examination of Givaudan’s recent M&A activity reveals a highly strategic and intelligent approach to growth. Rather than pursuing large, scale-building mega-mergers, the company focuses on smaller, targeted “bolt-on” acquisitions designed to bring specific, high-growth capabilities into the organization.34 The acquisitions of Vollmens (local customer access in Brazil), Custom Essence (natural perfumery), DDW (natural colors), Amyris’ ingredients (sustainable beauty), and Myrissi (AI in fragrance) all fit this pattern. This strategy allows Givaudan to use its massive global distribution and manufacturing platform as a force multiplier. It can acquire a niche technology or a specialized capability and “plug it in” to its global engine, rapidly scaling the acquired innovation across its vast customer base. This is a lower-risk, higher-return approach to M&A that allows the company to remain at the cutting edge of innovation without the immense integration risks and capital outlay of transformative deals.

VII. Capital Allocation & Financial Strategy

Givaudan’s financial strategy is characterized by discipline, consistency, and a clear focus on creating long-term shareholder value. The company’s robust free cash flow generation provides the foundation for a balanced capital allocation framework that prioritizes reinvestment for growth while also providing direct returns to shareholders.

A. Capital Allocation Framework

Management has consistently communicated a clear and disciplined set of capital allocation priorities, which are executed in the following order:

  1. Organic Investment: The first call on capital is reinvestment back into the business to drive organic growth. This includes capital expenditures (CapEx) for maintaining and expanding its global production footprint and, most importantly, sustained, industry-leading investment in Research & Development (R&D).43
  2. Value-Creating M&A: The company actively seeks bolt-on acquisitions that align with its strategic goals. These deals are targeted to expand the company’s capabilities, particularly in high-growth areas like naturals, health and wellbeing, and active beauty, or to enhance its access to local and regional customers.34
  3. Return of Capital to Shareholders: After funding organic growth and strategic M&A, the company is committed to returning excess cash to its shareholders, primarily through a progressive dividend.49

Share buybacks have been used in the past but are not currently a primary pillar of the capital return policy.13

B. Track Record for Acquisitions

Givaudan has a long and successful history of integrating acquisitions to enhance its market position and capabilities, dating back to the foundational acquisitions of Roure and Tastemaker.1 In recent years, the company has executed a string of strategic bolt-on acquisitions that have expanded its portfolio into new, attractive adjacencies. Key examples include Naturex (natural extracts), DDW (natural colors), Custom Essence (natural perfumery), and various players in the Active Beauty space.34 In its financial communications, management has consistently highlighted the successful integration of these businesses and their contribution to the company’s growth and expanded capabilities.46

C. Dividend Policy & Payout Ratios

Givaudan’s dividend policy is a cornerstone of its shareholder return proposition. The company has a stated objective of paying a progressive dividend that increases over time, reflecting the underlying growth in its cash flows.49

This commitment has been demonstrated through an exceptional track record. Following the proposed dividend of CHF 70.00 per share for the 2024 fiscal year, the company will have increased its dividend for 24 consecutive years since its IPO in 2000.12 This puts Givaudan on the cusp of joining the exclusive ranks of “Dividend Aristocrats.” The dividend is well-supported by the company’s strong free cash flow generation, resulting in a sustainable payout ratio that was approximately 59% of TTM earnings.40

D. Debt Levels & Financial Flexibility

Givaudan maintains a prudent and conservative approach to its balance sheet. As of December 2024, the company’s net debt stood at approximately CHF 4.0 billion.14 The key leverage metric, net debt to EBITDA, was a comfortable 2.3x at year-end 2024.14 This is well within the typical range for a stable, highly cash-generative business and provides Givaudan with significant financial flexibility. This strong balance sheet ensures the company has ample capacity to continue funding its organic growth initiatives and to act decisively on strategic M&A opportunities as they arise.

VIII. Recent Challenges & Industry Headwinds (2022-2024)

Despite its resilient business model, Givaudan has navigated a series of significant macroeconomic and industry-specific challenges in the 2022-2024 period. The company’s performance and management commentary during this time provide valuable insights into its operational resilience and strategic responses.

A. Inflation & Cost Pressures

The global inflationary spike of 2022 and early 2023 presented a major headwind, with the company facing significant increases in the cost of raw materials, energy, and logistics. However, Givaudan demonstrated exceptional pricing power, a key attribute of its wide economic moat. Management repeatedly stated in its 2023 earnings communications that it had successfully implemented price increases to “fully compensate” for these higher input costs, thereby protecting its profitability.10 By 2024, the situation had eased, with management noting a “generally benign raw materials price environment” that contributed to the year’s strong margin expansion.11

B. Supply Chain & Geopolitical Tensions

The post-pandemic recovery period continued to present supply chain challenges, which were exacerbated by geopolitical events, most notably the Russia-Ukraine conflict.44 This conflict has had a broad impact on the European chemical sector, primarily through elevated energy costs and disruptions to the supply of specific raw materials sourced from the region, such as ammonia and certain chemical precursors.50 Givaudan’s formal risk management framework explicitly identifies the “disruption of supply chains/suppliers” due to geopolitical tensions as a key operational risk, which it seeks to mitigate through comprehensive business continuity planning and a globally diversified sourcing strategy.52

C. Regulatory Changes & Antitrust Probe

The regulatory landscape, particularly in Europe, is becoming increasingly stringent, posing a long-term challenge for the entire F&F industry. A recent example is the EU’s decision to ban eight specific smoke flavorings due to genotoxicity concerns, with a phase-out period extending to 2029-2031.21 While this specific ban may not have a material direct impact on Givaudan, it is indicative of a broader trend towards stricter scrutiny of chemical ingredients, which could lead to increased R&D costs and the need for product reformulations in the future.

A more immediate and significant concern is the industry-wide antitrust investigation launched by European and Swiss authorities. In March 2023, Givaudan confirmed that it was a target of this probe, which is examining a possible price-fixing cartel in the supply of fragrances and ingredients.1 This investigation represents a material contingent liability, with the potential for significant financial penalties and reputational damage. The issue remains unresolved and creates a notable overhang of uncertainty for the company and its peers.

D. Consumer Behavior Shifts & Currency Headwinds

Givaudan’s financial results in 2023 were directly impacted by shifts in consumer behavior and customer inventory management. The company experienced negative volume growth for the year, which management attributed to widespread customer destocking following the supply chain volatility of the prior year, as well as the effects of “shrinkflation” (reducing product size while keeping the price constant) by CPG companies in response to inflation.45 These volumes saw a strong recovery in 2024.

A persistent and significant headwind for Givaudan is the strength of its reporting currency, the Swiss Franc (CHF). As a Swiss-domiciled company earning the vast majority of its revenue in other currencies (like the USD and EUR), a strong CHF negatively impacts its reported financial results. This “translational” headwind consistently reduces the company’s reported sales and profit growth in CHF terms. For instance, in fiscal year 2023, Givaudan’s LFL growth in local currencies was a solid +4.1%, but after currency conversion, its reported sales in CHF actually declined by -2.8%.10 This is a crucial factor for investors to consider when analyzing the company’s reported financials.

IX. Management Quality & Corporate Governance

The quality and stability of Givaudan’s leadership team and the robustness of its corporate governance framework are key pillars of the company’s long-term success and investment appeal.

A. Management Team Experience and Tenure

Givaudan is led by a highly experienced and stable executive team, characterized by exceptionally long tenures within the company. This provides a level of strategic continuity that is rare in the corporate world.

  • CEO Gilles Andrier: Mr. Andrier has served as Chief Executive Officer since March 2005, a tenure of nearly two decades.53 He joined Givaudan in 1993 and has held numerous leadership roles across the organization. His long stewardship has been instrumental in shaping the company’s successful strategy of disciplined growth, bolt-on M&A, and consistent shareholder returns.
  • Executive Committee: The broader Executive Committee boasts an average tenure of approximately 20 years with the company.55 This deep well of industry knowledge and internal experience fosters a consistent corporate culture and ensures a thorough understanding of the company’s complex operations.

While this stability is a significant strength, it also introduces a material long-term consideration. The long and successful tenure of the CEO, who is now 64 years old 53, naturally brings the topic of succession planning to the forefront. His leadership is deeply intertwined with the company’s modern identity and success. An eventual transition could introduce a period of strategic uncertainty. Although the Board of Directors states that it continuously discusses succession planning 56, the external visibility into this process is inherently low. This “key-person risk” and the opacity of the long-term succession plan represent a notable, albeit difficult to quantify, risk for long-term investors.

B. Strategic Vision & Execution

Givaudan’s management team has an exemplary track record of setting clear, long-term strategic goals and executing against them. The company operates on five-year strategic cycles, and it successfully delivered on its ambitious targets for the 2016-2020 cycle.43 It is currently well on track to exceed the high end of its growth targets for the current 2021-2025 strategic plan.12 This history of credible guidance and consistent execution lends a high degree of confidence to management’s strategic vision.

C. Board Composition & Corporate Governance

Givaudan adheres to high standards of corporate governance, which serves to protect shareholder interests.

  • Board Independence: A standout feature is that 100% of the members of the Board of Directors are non-executive and independent.14 This structure ensures robust oversight and minimizes potential conflicts of interest, which is a hallmark of best-in-class governance.
  • Board Committees: The Board operates through four specialized committees: Audit, Compensation, Nomination and Governance, and a dedicated Innovation Committee.56 The existence of an Innovation Committee at the board level is particularly noteworthy, as it underscores the strategic centrality of R&D and innovation to the company’s long-term value creation.

D. Management Communication

The company’s communication with the investment community is generally transparent, professional, and consistent. Givaudan provides detailed financial reporting, including comprehensive presentations, media releases, and full transcripts of its earnings conference calls, which are made readily available on its investor relations website.11 This allows for a thorough analysis of the company’s performance and strategic direction.

X. Valuation Analysis

Valuing Givaudan requires a nuanced approach that acknowledges both its superior quality and its correspondingly high market valuation. The central question for an investor is not whether the company deserves to trade at a premium to the market, but whether the current premium adequately reflects its future growth prospects and inherent risks. This analysis utilizes multiple valuation methodologies to provide a comprehensive perspective.

A. Comparable Company Analysis

A comparison with its industry peers reveals that Givaudan consistently trades at a premium valuation, which is supported by its superior profitability and returns.

  • Price-to-Earnings (P/E) Ratio: Givaudan’s trailing twelve-month (TTM) P/E ratio is approximately 30.0x.40 This is significantly higher than the broader market average and is at the upper end of its direct peer group. For context, historical data shows that the company’s P/E has averaged around 35.3x over the last ten years, indicating that the current multiple is not anomalous by its own historical standards.59
  • Enterprise Value-to-EBITDA (EV/EBITDA) Ratio: This metric, which is often preferred for comparing companies with different capital structures and tax rates, also shows a premium. Givaudan’s TTM EV/EBITDA multiple is in the range of 21.0x to 24.0x.40 As shown in Table 1, this is substantially higher than the multiples for IFF and dsm-firmenich, but more in line with Symrise, reflecting Givaudan’s industry-leading EBITDA margins.

This persistent valuation premium is a direct reflection of the market’s recognition of Givaudan’s wide economic moat, its stable and defensive growth profile, its strong pricing power, and its consistent free cash flow generation.

B. Discounted Cash Flow (DCF) Analysis

A discounted cash flow (DCF) analysis can be used to estimate the intrinsic value of Givaudan based on its future cash generation potential. While a full DCF model is not constructed here, the key inputs for such an analysis are as follows:

  • Risk-Free Rate: The appropriate risk-free rate would be based on a long-term Swiss government bond. The current yield on the Switzerland 10-Year Government Bond is approximately 0.3% to 0.4%.61 This extremely low rate is a significant factor in valuation models.
  • Equity Risk Premium (ERP): An appropriate ERP for a stable, global company like Givaudan would need to be determined, likely a blend of the Swiss market premium and the weighted average premium of the markets in which it operates.
  • Beta: Givaudan’s stock exhibits low volatility, reflecting its defensive business nature. One source cites a beta of 0.35.65 An analyst would typically unlever this beta and then re-lever it based on the company’s target capital structure to derive a forward-looking beta for the cost of equity calculation.
  • Forecast Period (5 Years): Revenue growth assumptions would likely start near the recent trend and gradually taper down towards the long-term industry growth rate of around 4%. EBITDA margin assumptions would likely be held near the strong 2024 levels, reflecting sustained pricing power and operational efficiency. Free cash flow conversion would be modeled based on management’s target of >12% of sales.
  • Terminal Value: The terminal value would be calculated using a perpetual growth rate, likely in the range of 2.0% to 2.5%, reflecting long-term global GDP and inflation expectations.

C. Valuation Synthesis

The collective analysis from comparable multiples and the framework for a DCF suggests that Givaudan is a company that the market values highly, and for rational reasons. Its premium multiples are a direct consequence of its superior and more predictable financial performance compared to its peers. The core debate for an investor is one of value versus quality. The current valuation appears to fully price in the company’s excellent prospects, leaving little margin of safety for potential disappointments in growth or profitability. An investment at current levels is a bet that the company can continue its flawless execution and that its quality will continue to command a premium in the market.

XI. Key Risks & Risk Assessment

A comprehensive analysis of Givaudan requires a thorough assessment of the key risks that could impact its financial performance and strategic objectives. These risks can be categorized into business, financial, ESG/regulatory, and market risks.

A. Business & Operational Risks

  • Raw Material Price & Availability Volatility: This is arguably the most significant operational risk for Givaudan. The company’s gross margins are directly exposed to fluctuations in the prices of its vast array of natural and synthetic raw materials. While Givaudan has demonstrated strong pricing power to offset inflation, a sudden and sharp spike in input costs could temporarily compress margins. Furthermore, the availability of natural ingredients can be disrupted by factors such as adverse weather, crop failures, or geopolitical issues in sourcing regions.52
  • Supply Chain Disruption: The company’s complex global supply chain is vulnerable to disruption from geopolitical events, pandemics, trade disputes, and logistics bottlenecks. Any significant interruption could impact its ability to produce and deliver products in a timely manner.52
  • Operational Safety and Environmental Incidents: Operating large-scale chemical production facilities carries inherent risks. The tragic explosion at Givaudan’s facility in Louisville, USA, in 2024, which resulted in fatalities, is a stark reminder of this risk.66 Such incidents can lead to production halts, significant financial costs, and severe reputational damage.

B. Financial Risks

  • Currency Exposure: As a Swiss-domiciled company with the majority of its sales and costs in foreign currencies (USD, EUR, etc.), Givaudan has significant exposure to foreign exchange (FX) risk. The primary risk is a persistently strong Swiss Franc (CHF), which creates a “translational” headwind that reduces the value of foreign earnings when converted back to CHF for reporting purposes. This has been a consistent drag on reported growth in recent years.52
  • Leverage and Credit Risk: While Givaudan’s balance sheet is currently managed prudently, future large-scale M&A activity could increase its debt levels and financial leverage. A significant increase in debt could constrain financial flexibility and increase sensitivity to interest rate changes.52

C. ESG & Regulatory Risks

  • Regulatory Scrutiny of Ingredients: This is a major and growing risk. Regulatory bodies, particularly in the European Union, are increasing their scrutiny of chemical substances used in consumer products. The potential for ingredients to be banned or restricted could force Givaudan to undertake costly R&D and reformulation efforts, or even to remove certain ingredients from its palette entirely.20
  • Antitrust Investigation: The ongoing industry-wide cartel investigation by European and Swiss authorities is a critical risk factor.1 An adverse finding could result in substantial fines, litigation costs, and significant damage to the company’s reputation and customer relationships. The uncertainty surrounding the outcome of this probe remains a major overhang on the stock.
  • Climate Change Impact on Sourcing: For a company increasingly focused on natural ingredients, climate change poses a significant long-term risk. Changing weather patterns, droughts, and loss of biodiversity could threaten the long-term supply and increase the volatility of key botanical raw materials, a cornerstone of the company’s growth strategy.52

D. Market Risks

  • Changes in Consumer Spending: While the bulk of Givaudan’s business is tied to defensive consumer staples, a portion, particularly the Fine Fragrance segment, is more discretionary. A severe and prolonged global recession could lead to a downturn in consumer spending on luxury goods, impacting this high-margin part of the business.
  • Intensified Competition: The F&F industry is an oligopoly, but competition remains intense, primarily on the basis of innovation and service. The recent merger of DSM and Firmenich has created a larger, more formidable competitor, which could increase competitive pressure over the long term.25

XII. Investment Thesis Summary

The investment thesis for Givaudan SA is a classic study in the trade-off between exceptional quality and premium valuation. The analysis synthesizes to a clear, albeit complex, conclusion regarding the company’s position as an investment candidate for a long-term, quality-focused portfolio.

A. Synthesis of Merits and Concerns

Givaudan represents a best-in-class global leader operating within a structurally attractive, oligopolistic industry. Its formidable competitive moat is built upon decades of investment in R&D, a deeply integrated co-creation model with its customers, and a mastery of complex global supply chains and regulatory environments. This has translated into a superior financial profile characterized by resilient, above-market growth, demonstrable pricing power, and the consistent generation of strong free cash flow. The company’s disciplined capital allocation strategy, which prioritizes organic reinvestment and a progressive dividend, has delivered compounding returns to shareholders for over two decades.

These outstanding qualities are, however, fully recognized by the market. The primary investment concern is the company’s perennially high valuation, which trades at a significant premium to the broader market and most peers. This premium valuation leaves little margin of safety for investors in the event of an operational misstep or a deterioration in the macroeconomic environment. The company faces tangible risks from the persistent strength of the Swiss Franc, which dampens reported results, and the volatility of raw material costs. Furthermore, two significant, unresolved issues present material risks: the increasing stringency of chemical regulations globally and the major overhang of uncertainty from the ongoing industry-wide antitrust investigation.

B. Critical Factors Driving Future Performance

For an investor monitoring Givaudan, future performance will be contingent on several critical factors:

  1. The Volume/Price Dynamic: The ability to continue driving healthy volume growth while maintaining the pricing discipline necessary to protect industry-leading margins will be paramount.
  2. Success in Strategic Adjacencies: The growth and, crucially, the profitability of its strategic initiatives in Active Beauty, Health & Wellbeing, and natural ingredients will be key to sustaining above-market growth.
  3. Local and Regional Customer Penetration: Continued market share gains with the faster-growing cohort of local and regional brands, particularly in emerging markets, is a key growth lever.
  4. Resolution of the Antitrust Probe: The outcome of the cartel investigation is the most significant idiosyncratic risk. A favorable or manageable resolution would remove a major uncertainty, while a severe penalty could have a material financial and reputational impact.

C. Investment Time Horizon and Defining Success

An investment in Givaudan is most appropriately viewed through a long-term lens, suitable for an investor with a time horizon of five years or more who prioritizes quality, predictability, and compounding growth over deep value.

Success for a long-term investment in Givaudan would be defined by the company’s continued execution of its stated strategy. This would involve achieving its 2025 financial targets of 4-5% average LFL sales growth and a free cash flow to sales ratio of over 12%. It would also require the maintenance of its industry-leading EBITDA margins and the continuation of its progressive dividend policy. Ultimately, success would manifest as long-term share price appreciation that is broadly in line with the company’s underlying growth in earnings and cash flow per share, reaffirming its status as a premier compounder in the global market.

Works cited

  1. Givaudan – Wikipedia, accessed August 4, 2025, https://en.wikipedia.org/wiki/Givaudan
  2. GIVAUDAN SA ADR EACH 50 REPR 1 ORD Company Profile & Introduction – Moomoo, accessed August 4, 2025, https://www.moomoo.com/stock/GVDNY-US/company
  3. Givaudan (GVDBF) Stock Price & Overview, accessed August 4, 2025, https://stockanalysis.com/quote/otc/GVDBF/
  4. Our Company – Givaudan, accessed August 4, 2025, https://www.givaudan.com/our-company
  5. 2025 Investor Presentation – Givaudan, accessed August 4, 2025, https://www.givaudan.com/files/giv-2025-investor-presentation-jan.pdf
  6. About Givaudan | Givaudan, accessed August 4, 2025, https://www.givaudan.com/our-company/about-givaudan
  7. INTEGRATED ANNUAL REPORT – Givaudan, accessed August 4, 2025, https://www.givaudan.com/sites/givaudanweb.int/files/2022-02/GIV_2021_IntegratedAnnualReport_2.pdf
  8. Reason 4: A research-driven innovation process | Givaudan, accessed August 4, 2025, https://www.givaudan.com/investors/investor-information/investment-case/reason-4
  9. Company news | Givaudan, accessed August 4, 2025, https://www.givaudan.com/media/media-releases
  10. 2023 Full year results | Givaudan, accessed August 4, 2025, https://www.givaudan.com/media/media-releases/2024/2023-full-year-results
  11. Givaudan SA (GVDBF) Full Year 2024 Earnings Call Transcript | Seeking Alpha, accessed August 4, 2025, https://seekingalpha.com/article/4751855-givaudan-sa-gvdbf-full-year-2024-earnings-call-transcript
  12. 2024 Full year results | Givaudan, accessed August 4, 2025, https://www.givaudan.com/media/media-releases/2025/2024-full-year-results
  13. Givaudan – SEC.gov, accessed August 4, 2025, https://www.sec.gov/Archives/edgar/vprr/0800/08004760.pdf
  14. 2024 Integrated Report | Givaudan, accessed August 4, 2025, https://www.givaudan.com/files/giv-2024-integrated-report.pdf
  15. investor presentation february 2022 – Givaudan, accessed August 4, 2025, https://www.givaudan.com/files/giv-2022-investor-presentation-feb.pdf
  16. Flavors and Fragrances Market Size, Industry Share Forecast [Latest], accessed August 4, 2025, https://www.marketsandmarkets.com/Market-Reports/flavors-fragrance-market-175163912.html
  17. Flavors And Fragrances Market Size, Growth Drivers & Forecast, 2030, accessed August 4, 2025, https://www.mordorintelligence.com/industry-reports/flavor-and-fragrance-market
  18. Flavors And Fragrances Market Size & Share Report, 2030 – Grand View Research, accessed August 4, 2025, https://www.grandviewresearch.com/industry-analysis/flavors-fragrances-market
  19. Our innovative capabilities – Givaudan, accessed August 4, 2025, https://www.givaudan.com/files/giv-2018-innovation.pdf
  20. EU withdraws eight flavourings | AGRINFO, accessed August 4, 2025, https://agrinfo.eu/book-of-reports/eu-withdraws-eight-flavourings/pdf/
  21. Smoke signals: How will the EU’s flavour ban impact the food industry? | FoodBev Media, accessed August 4, 2025, https://www.foodbev.com/news/smoke-signals-how-will-the-eu-s-flavour-ban-impact-the-food-industry
  22. What requirements must herbs and spices meet to be allowed on the European market?, accessed August 4, 2025, https://www.cbi.eu/market-information/spices-herbs/buyer-requirements
  23. EU Rules – flavourings – Food Safety – European Union, accessed August 4, 2025, https://food.ec.europa.eu/food-safety/food-improvement-agents/flavourings/eu-rules_en
  24. Flavors & Fragrances Companies – MarketsandMarkets, accessed August 4, 2025, https://www.marketsandmarkets.com/ResearchInsight/flavors-fragrance-market.asp
  25. Firmenich’s archive – Investors, accessed August 4, 2025, https://investors.dsm-firmenich.com/en/investors/historical-information/firmenich-investors.html
  26. U.S. Flavors And Fragrances Market | Industry Report, 2030 – Grand View Research, accessed August 4, 2025, https://www.grandviewresearch.com/industry-analysis/us-flavors-fragrances-market-report
  27. Flavors and Fragrances Market Future Demand, Forecast 2024-30, accessed August 4, 2025, https://www.forinsightsconsultancy.com/reports/flavors-and-fragrances-market
  28. Flavors and Fragrances Market Size, Demand & Growth by 2033 – Straits Research, accessed August 4, 2025, https://straitsresearch.com/report/flavors-and-fragrances-market
  29. Sustainability – Givaudan, accessed August 4, 2025, https://www.givaudan.com/sustainability
  30. Givaudan SA – Company ESG Risk Rating – Sustainalytics, accessed August 4, 2025, https://www.sustainalytics.com/esg-rating/givaudan-sa/1009389420
  31. Investors – DSM-Firmenich, accessed August 4, 2025, https://investors.dsm-firmenich.com/en/investors.html
  32. DSM B.V. publishes 2024 Annual Report, accessed August 4, 2025, https://our-company.dsm-firmenich.com/en/our-company/news/press-releases/legacy-archive/2025/dsm-bv-publishes-2024-annual-report.html
  33. 2023 Integrated Report | Givaudan, accessed August 4, 2025, https://www.givaudan.com/files/giv-2023-integrated-report.pdf
  34. Our acquisitions | Givaudan, accessed August 4, 2025, https://www.givaudan.com/investors/investor-information/investment-case/our-acquisitions
  35. Givaudan 2024 Leaders & Newsmakers | Perfumer & Flavorist, accessed August 4, 2025, https://www.perfumerflavorist.com/flavor/ingredients/news/22910393/givaudan-givaudan-2024-leaders-newsmakers
  36. IFF Reports Fourth Quarter and Full Year 2024 Results …, accessed August 4, 2025, https://ir.iff.com/news-releases/news-release-details/iff-reports-fourth-quarter-and-full-year-2024-results
  37. The most important information for investors – Symrise, accessed August 4, 2025, https://www.symrise.com/investors/
  38. dsm-firmenich publishes 2024 Integrated Annual Report, accessed August 4, 2025, https://our-company.dsm-firmenich.com/en/our-company/news/press-releases/2025/dsm-firmenich-publishes-2024-integrated-annual-report.html
  39. Financial results | Givaudan, accessed August 4, 2025, https://www.givaudan.com/investors/financial-results
  40. Givaudan (SWX:GIVN) Statistics & Valuation Metrics – Stock Analysis, accessed August 4, 2025, https://stockanalysis.com/quote/swx/GIVN/statistics/
  41. Corporate Report 2024 Sharing Values – Symrise, accessed August 4, 2025, https://symrise.com/corporatereport/2024/home/Symrise_Unternehmensbericht_24_EN_interaktiv_geschuetzt.pdf
  42. GIVN Relative Valuation – Givaudan SA – Alpha Spread, accessed August 4, 2025, https://www.alphaspread.com/security/six/givn/relative-valuation
  43. Financial targets | Givaudan, accessed August 4, 2025, https://www.givaudan.com/investors/financial-results/financial-targets
  44. 2022 Full year results | Givaudan, accessed August 4, 2025, https://www.givaudan.com/media/media-releases/2023/2022-full-year-results
  45. Transcript 2023 Full Year Results – Givaudan, accessed August 4, 2025, https://www.givaudan.com/files/giv-transcript-2023-full-year-results.pdf
  46. Transcript 2024 Full Year Results – Givaudan, accessed August 4, 2025, https://www.givaudan.com/files/giv-transcript-2024-full-year-results.pdf
  47. Givaudan (GVDNY) Statistics & Valuation Metrics – Stock Analysis, accessed August 4, 2025, https://stockanalysis.com/quote/otc/GVDNY/statistics/
  48. Givaudan | Flavours and fragrances to create for happier, healthier lives, accessed August 4, 2025, https://www.givaudan.com/
  49. Dividend | Givaudan, accessed August 4, 2025, https://www.givaudan.com/investors/investor-information/dividend
  50. Impact of Russia-Ukraine War on the Chemical Industry – TechSci Research, accessed August 4, 2025, https://www.techsciresearch.com/blog/impact-of-russia-ukraine-war-on-the-chemical-industry/1335.html
  51. Local Disruptions with Global Implications: How the War Affects the …, accessed August 4, 2025, https://www.bain.com/insights/local-disruptions-with-global-implications/
  52. Risk management | Givaudan, accessed August 4, 2025, https://www.givaudan.com/investors/corporate-governance/risk-management
  53. Givaudan SA (GIVN N) Leadership & Management Team Analysis – Simply Wall St, accessed August 4, 2025, https://simplywall.st/stocks/mx/materials/bmv-givn-n/givaudan-shares/management
  54. Meet our leadership | Givaudan, accessed August 4, 2025, https://www.givaudan.com/our-company/about-givaudan/our-leadership
  55. Executive Committee – Givaudan, accessed August 4, 2025, https://www.givaudan.com/investors/corporate-governance/executive-committee
  56. Board of Directors – Givaudan, accessed August 4, 2025, https://www.givaudan.com/investors/corporate-governance/board-of-directors
  57. Board of Directors | Givaudan Integrated Report, accessed August 4, 2025, https://integratedreport.givaudan.com/2024/year-review/governance/bod
  58. Transcript Q&A 2023 Half Year Results – Givaudan, accessed August 4, 2025, https://www.givaudan.com/files/giv-transcript-qa-2024-half-year-results.pdf
  59. Givaudan S.A. – PE Ratio – Wisesheets, accessed August 4, 2025, https://www.wisesheets.io/pe-ratio/GIVN.SW
  60. Givaudan – Public Comps and Valuation Multiples, accessed August 4, 2025, https://multiples.vc/public-comps/givaudan-valuation-multiples
  61. Switzerland – 10-Year Government Bond Yield (1955-2025) – Macrotrends, accessed August 4, 2025, https://www.macrotrends.net/4004/switzerland-10-year-government-bond-yield
  62. Switzerland 10-Year Bond Yield Forecast Q4 2025 – Cbonds, accessed August 4, 2025, https://cbonds.com/indexes/160635/
  63. Switzerland 10-Year Government Bond Yield – Quote – Chart – Historical Data – News, accessed August 4, 2025, https://tradingeconomics.com/switzerland/government-bond-yield
  64. Switzerland Average Long-term Government Bond | Moody’s Analytics – Economy.com, accessed August 4, 2025, https://www.economy.com/switzerland/average-long-term-government-bond
  65. Givaudan SA (DE:GIN1) Stock Statistics & Valuation Metrics – TipRanks.com, accessed August 4, 2025, https://www.tipranks.com/stocks/de:gin1/statistics
  66. 2024 Givaudan and ESG, accessed August 4, 2025, https://www.givaudan.com/files/giv-2024-givaudan-and-esg.pdf
  67. Risk management | Givaudan Integrated Report, accessed August 4, 2025, https://integratedreport.givaudan.com/2024/value-creation/risk-management